The Scientist

» Big Pharma and cell & molecular biology

Most Recent

image: Editing Genomes to Record Cellular Histories

Editing Genomes to Record Cellular Histories

By | May 26, 2016

Researchers harness the power of genome editing to track cell lineages throughout zebrafish development.

0 Comments

image: Pfizer Scoops Anacor for $5.3 Billion

Pfizer Scoops Anacor for $5.3 Billion

By | May 17, 2016

The acquisition-hungry pharmaceutical firm is purchasing the California-based eczema gel maker.

0 Comments

image: Embryo Watch

Embryo Watch

By | May 5, 2016

A new culture system allows researchers to track the development of human embryos in vitro for nearly two weeks.

1 Comment

image: Observing the Nuclear Pore

Observing the Nuclear Pore

By | May 2, 2016

Scientists visualize nuclear pore complexes for the first time, using high-speed atomic force microscopy.

1 Comment

image: Fuchs on the Future

Fuchs on the Future

By | May 1, 2016

Rockefeller University researcher Elaine Fuchs on being a woman in science and her contributions to the burgeoning field of reverse genetics

0 Comments

image: Instant Messaging

Instant Messaging

By | May 1, 2016

An alternative route to sparking cell signals involves hook-ups between transmembrane and soluble ligands.

0 Comments

image: More Than Skin Deep

More Than Skin Deep

By | May 1, 2016

Elaine Fuchs has worked on adult stem cells since before they were so named, figuring out how multipotent epidermal cells renew or turn into skin or hair follicles.

1 Comment

image: “Hunger Hormone” No More?

“Hunger Hormone” No More?

By | April 20, 2016

Ghrelin promotes fat storage not feeding, according to a study.

3 Comments

image: Zooming In on an Antidepressant Target

Zooming In on an Antidepressant Target

By | April 6, 2016

Structural studies reveal how SSRI drugs bind to the human serotonin transporter.

0 Comments

image: New Epigenetic Mark Confirmed in Mammals

New Epigenetic Mark Confirmed in Mammals

By | April 1, 2016

Methylation on adenine bases is involved in the dampening of gene expression in mammalian cells, according to a study.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS